Survival-associated meQTLs across different cancer types
We identified 23,432 meQTLs associated with patient overall survival across different cancer types at FDR < 0.05.
Cancer type
|
SNP ID
|
SNP position (hg19)
|
Alleles (A/a)
|
log-rank test p-value
|
Sample size
|
Median survival time AA
|
Median survival time Aa
|
Median survival time aa
|
|
---|---|---|---|---|---|---|---|---|---|
PCPG | rs2260296 | chr13:114174141 | A/C | 3.99E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2260297 | chr13:114174283 | A/G | 0.000412 | 177 | 23.82 | 29.5 | 3.7 | KM Plot |
PCPG | rs2260303 | chr13:114174575 | T/C | 0.000389 | 178 | 24.1 | 29.5 | 3.7 | KM Plot |
PCPG | rs2260304 | chr13:114150795 | A/G | 5.27E-12 | 176 | 24.23 | 29.57 | 3.32 | KM Plot |
PCPG | rs2260332 | chr13:114174753 | C/T | 3.99E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2260334 | chr13:114175004 | A/G | 0.000387 | 178 | 3.7 | 29.43 | 24.17 | KM Plot |
PCPG | rs2260335 | chr13:114175032 | G/A | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2260340 | chr13:114175300 | C/G | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2260377 | chr13:114176028 | A/T | 0.000389 | 178 | 24.1 | 29.5 | 3.7 | KM Plot |
PCPG | rs2260381 | chr13:114176323 | T/G | 3.87E-12 | 178 | 24.17 | 29.95 | 3.32 | KM Plot |
PCPG | rs2260382 | chr13:114176365 | C/T | 0.000389 | 178 | 24.1 | 29.5 | 3.7 | KM Plot |
PCPG | rs2260470 | chr13:114177725 | C/T | 4.67E-12 | 177 | 24.17 | 30.33 | 3.32 | KM Plot |
PCPG | rs2260800 | chr13:114138622 | A/G | 4.2E-12 | 175 | 24.23 | 29.95 | 3.32 | KM Plot |
PCPG | rs2260814 | chr13:114186178 | G/A | 5.45E-12 | 176 | 24.1 | 30.33 | 3.32 | KM Plot |
PCPG | rs2260816 | chr13:114186112 | T/C | 6.48E-12 | 174 | 24.17 | 29.95 | 3.32 | KM Plot |